Please assess the completion status of the following clinical trial:

Trial Title: Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients, aged 30-80 years, with CAD confirmed by coronarography with at least 50% stenosis of one large epicardial coronary artery.~Exclusion Criteria:~* planned cardiovascular surgery within 6 months, congestive heart failure NYHA III/IV, evolving renal failure, neoplastic disease, psycho-organic disorder or any factor impeding follow-up, contraindication to vaccination.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- active vaccine (Type: EXPERIMENTAL): patients received active influenza vaccine for season 2004/2005
- placebo vaccine (Type: PLACEBO_COMPARATOR): patients received placebo influenza vaccine for season 2004/2005 containing all vaccine compounds except viral antigens

Based on this trial design, predict the completion outcome and termination type (if applicable).